This trial is an open, single arm, single center, prospective phase II clinical study.
Objective:To observe the efficacy and safety of Fruquintinib in the first-line treatment of
desmoplastic small round cell tumor, epithelioid hemangioendothelioma, solitary fibroma or
second-line and posterior line treatment of angiosarcoma.
How understandable was the trial content above?
Hard to understand
Easy to understand